Cargando…

The Predictive Role of Immune Related Subgroup Classification in Immune Checkpoint Blockade Therapy for Lung Adenocarcinoma

Background: In lung adenocarcinoma (LUAD), the predictive role of immune-related subgroup classification in immune checkpoint blockade (ICB) therapy remains largely incomplete. Methods: Transcriptomics analysis was performed to evaluate the association between immune landscape and ICB therapy in lun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Xiaozhou, Wang, Ziyang, Chen, Yiwen, Yin, Guotao, Liu, Jianjing, Chen, Wei, Zhu, Lei, Xu, Wengui, Li, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554034/ https://www.ncbi.nlm.nih.gov/pubmed/34721552 http://dx.doi.org/10.3389/fgene.2021.771830

Ejemplares similares

Prediction of EGFR Mutation Status Based on (18)F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma
por: Yin, Guotao, et al.
Publicado: (2021)

Corrigendum: Prediction of EGFR Mutation Status Based on (18)F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma
por: Yin, Guotao, et al.
Publicado: (2021)

Immune Landscape and Classification in Lung Adenocarcinoma Based on a Novel Cell Cycle Checkpoints Related Signature for Predicting Prognosis and Therapeutic Response
por: Yang, Jian, et al.
Publicado: (2022)

Reclassifying TNM stage I/II colorectal cancer into two subgroups with different overall survival, tumor microenvironment, and response to immune checkpoint blockade treatment
por: Liu, Xiangxiang, et al.
Publicado: (2022)

A Gene Panel for Early Identification of Future Responders to Immune Checkpoint Blockade
por: Panda, Anshuman, et al.
Publicado: (2022)

Utilization of hypoxia-derived gene signatures to predict clinical outcomes and immune checkpoint blockade therapy responses in prostate cancer
por: Chen, Minhua, et al.
Publicado: (2022)

Enhanced glucose metabolism mediated by CD147 is associated with (18)F‐FDG PET/CT imaging in lung adenocarcinoma
por: Zhang, Yufan, et al.
Publicado: (2020)

Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy
por: Wang, Qinghua, et al.
Publicado: (2020)

Deep neural network classification based on somatic mutations potentially predicts clinical benefit of immune checkpoint blockade in lung adenocarcinoma
por: Peng, Jie, et al.
Publicado: (2020)

Immune Checkpoint Blockade Therapy for Hepatocellular Carcinoma: Clinical Challenges and Considerations
por: Zhang, Qi, et al.
Publicado: (2020)

Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma
por: Hu, Xinyao, et al.
Publicado: (2022)

Classification of Lung Adenocarcinoma Based on Immune Checkpoint and Screening of Related Genes
por: Zhou, Ting, et al.
Publicado: (2021)

GPR81-mediated reprogramming of glucose metabolism contributes to the immune landscape in breast cancer
por: li, Xiaofeng, et al.
Publicado: (2023)

Correlation between EGFR mutation status and F(18)‐fluorodeoxyglucose positron emission tomography‐computed tomography image features in lung adenocarcinoma
por: Zhu, Lei, et al.
Publicado: (2019)

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma
por: Hu, Xinyao, et al.
Publicado: (2023)

EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

Corticosteroids and immune checkpoint blockade
por: Min, Le, et al.
Publicado: (2015)

Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022)

Predictive Power of a Radiomic Signature Based on (18)F-FDG PET/CT Images for EGFR Mutational Status in NSCLC
por: Li, Xiaofeng, et al.
Publicado: (2019)

Clinical outcomes of immune checkpoint blockades and the underlying immune escape mechanisms in squamous and adenocarcinoma NSCLC
por: Tian, Yaru, et al.
Publicado: (2020)

Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
por: Wang, Jixin, et al.
Publicado: (2021)

Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma
por: Wang, Yufei, et al.
Publicado: (2022)

Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer Vaccine
por: Kadam, Pournima, et al.
Publicado: (2020)

Prognostic Implications and Immune Infiltration Analysis of ALDOA in Lung Adenocarcinoma
por: Lu, Guojun, et al.
Publicado: (2021)

Unlocking phenotypic plasticity provides novel insights for immunity and personalized therapy in lung adenocarcinoma
por: Wang, Feng, et al.
Publicado: (2022)

Mitochondrial Homeostasis–Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2022)

Identification and Validation of an Immune Evasion Molecular Subgroup of Patients With Colon Cancer for Implications of Immunotherapy
por: Zhang, Hongbin, et al.
Publicado: (2022)

Differential Infiltration of Immune Cells Driven by Tumor Heterogeneity Reveals Two Immune Subtypes in Lung Adenocarcinoma
por: Wang, Liqiang, et al.
Publicado: (2022)

Identification and validation of a hypoxia-immune signature for overall survival prediction in lung adenocarcinoma
por: Li, Yong, et al.
Publicado: (2022)

Immune checkpoint blockade in ovarian cancer
por: Weiss, Lukas, et al.
Publicado: (2016)

Hallmarks of response to immune checkpoint blockade
por: Cogdill, Alexandria P, et al.
Publicado: (2017)

Immune-Checkpoint Blockade Therapy in Lymphoma
por: Kuzume, Ayumi, et al.
Publicado: (2020)

Activation of phagocytosis by immune checkpoint blockade
por: Li, Chia-Wei, et al.
Publicado: (2018)

Neutrophils in the era of immune checkpoint blockade
por: Faget, Julien, et al.
Publicado: (2021)

Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2022)

Role of the CBX Molecular Family in Lung Adenocarcinoma Tumorigenesis and Immune Infiltration
por: Zhang, Chun, et al.
Publicado: (2021)

Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
por: Xia, Zhi, et al.
Publicado: (2022)

Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma
por: Yang, Weichang, et al.
Publicado: (2023)

Oxygen microcapsules improve immune checkpoint blockade by ameliorating hypoxia condition in pancreatic ductal adenocarcinoma
por: Wu, Jiangchao, et al.
Publicado: (2022)

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
por: Pabla, Sarabjot, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sogdrg4j0ft7vrp8o9olbip5n0